Sofosbuvir 100mg SOFOSBUVIR+VELPATASVIR (VELASOF)

Get a Price/Quote

MOQ : 10 Pieces

Sofosbuvir 100mg SOFOSBUVIR+VELPATASVIR (VELASOF) Specification

Origin of Medicine
India

Dosage
Sofosbuvir 400 mg + Velpatasvir 100 mg

Molecular Formula
Sofosbuvir: C22H29FN3O9P; Velpatasvir: C49H54N8O8

Dosage Form
Film-coated tablet

Medicine Type
Allopathic

Usage
For the treatment of chronic hepatitis C virus (HCV) infection

Grade
Pharmaceutical Grade

Salt Composition
Sofosbuvir 400 mg + Velpatasvir 100 mg

Pacakaging (Quantity Per Box)
28 Tablets (1 bottle per box)

Indication
Chronic Hepatitis C Infection

Expiration Date
24 to 36 months from manufacturing date

Storage
Store below 30C, protect from moisture and light

Appearance
Tablet

CAS No
1190307-88-0 (Sofosbuvir), 1377049-84-7 (Velpatasvir)

Assay
NLT 98% (for both actives)

Strength
Sofosbuvir 400 mg + Velpatasvir 100 mg per tablet

Packing Type
HDPE bottle in a carton

Prescription/Non prescription
Prescription only

Side Effects
Headache, fatigue, nausea, insomnia

Route of Administration
Oral

Marketed By
Hetero Healthcare Limited

Drug Class
Direct-acting Antiviral Agents (DAA)

Brand Name
Velasof

Therapeutic Class
Antiviral (Anti-HCV)

Available Pack Size
28 Tablets per bottle

Color
White to off-white tablet

Precautions
To be taken as directed by a physician. Not to be used in pediatric patients below 18 years unless prescribed.

Sofosbuvir 100mg SOFOSBUVIR+VELPATASVIR (VELASOF) About

Spotlight on Velasof: the formidable and acclaimed solution for chronic hepatitis C virus (HCV) infection. This exceptional antiviral combination brings Sofosbuvir 400 mg and Velpatasvir 100 mg together in a single, oral film-coated tablet. Marketed by Hetero Healthcare Limited, Velasof delivers pharmaceutical-grade efficacy and reliability, maintaining an assay of NLT 98% for both active constituents. Encased in HDPE bottles (28 tablets per pack), Velasof stands out for its excellent storage stability and prescription-only security. Experience the best in HCV management at the lowest price, with proven results and robust safety standards.

Premium Features and Versatile Clinical Application

Velasof's extra features include its once-daily dosage, pharmaceutical-grade formulation, and high assay value. It is specifically designed for oral administration in adults combating chronic HCV infection. With its potent direct-acting antiviral agents, Velasof is suited for general use under physician supervision and is not intended for patients under 18 unless prescribed. This allopathic medicine assures consistent quality, rapid absorption, and exceptional safety standards, making it a trusted choice for long-term HCV management.

Payment Terms, Local and International Distribution

Flexible payment terms are available for Velasof, facilitating seamless transactions for both domestic and international customers. Shipments are handled with care, utilizing robust packaging-HDPE bottles within cartons-to ensure product safety during freight. Precise estimates on delivery timelines and freight charges can be provided upon request. Velasof is widely available across major cities in India and is exported globally, ensuring its acclaimed efficacy reaches people worldwide with secure and prompt delivery solutions.

FAQ's of Sofosbuvir 100mg SOFOSBUVIR+VELPATASVIR (VELASOF):

Q: How should Velasof (Sofosbuvir + Velpatasvir) be taken?

A: Velasof should be administered orally as a once-daily dose, exactly as instructed by a physician. It is important not to alter the dosage or regimen without medical supervision.

Q: What makes Velasof exceptional in the treatment of chronic hepatitis C?

A: Velasof combines two direct-acting antiviral agents-Sofosbuvir and Velpatasvir-delivering a formidable, all-in-one regimen renowned for its robust efficacy, safety, and patient-friendly dosing.

Q: When can Velasof be used for pediatric patients?

A: Velasof should not be used in pediatric patients below 18 years unless specifically prescribed by a qualified healthcare professional.

Q: Where is Velasof manufactured and supplied?

A: Velasof is manufactured, supplied, and distributed by Hetero Healthcare Limited in India, with wide availability both locally and for international markets.

Q: What are the potential side effects of using Velasof?

A: Some users may experience headache, fatigue, nausea, or insomnia. If any adverse effects persist or worsen, consult your healthcare provider promptly.

Q: How is Velasof packaged for shipping and storage?

A: Each carton contains one HDPE bottle of 28 film-coated tablets. The packaging is designed to protect the product from moisture and light, ensuring stability during freight and storage below 30C.

Tell us about your requirement